Oncology – Nucleome Info

Oncology Tests

OncoTotal500

Comprehensive profiling of 500+ cancer-associated genes

Cancer genomic profiling assay for biomarkers in targeted and immunotherapy decisions.

Detects SNVs, InDels, CNVs, BRCA1/2 rearrangements, MSI, TMB, LOH, and fusions (FusionSync).

Covers 500+ genes including EGFR, BRAF, KRAS, ERBB2, MET, ALK, ROS1, RET, NTRK1/2/3.

Uses FFPE samples; 4 samples per Ion 540™ chip.

Book Test

OncoFocus52

Clinically focused 52-gene DNA & RNA panel for pancancer FFPE samples

Targeted gene profiling assay designed to detect clinically relevant oncogenic alterations.

Identifies hotspot mutations, SNVs, CNVs, and gene fusions using integrated DNA + RNA workflow.

Covers a focused panel of 52 key cancer-associated genes.

Uses FFPE tissue samples with a capacity of 64 samples per Ion 540™ Chip.

Book Test

BRCAssure

Complete BRCA1 & BRCA2 analysis for somatic and germline variants

Comprehensive genomic assay for detailed analysis of BRCA1 and BRCA2 genes.

Detects SNVs, InDels, and large exon/gene deletions and duplications across all coding regions.

Focused on BRCA1 and BRCA2, key genes linked to hereditary cancer risk.

Uses blood and FFPE tissue samples with a capacity of 48 BRCA-only samples.

Book Test

MyeloMap

Targeted 52-gene NGS panel for AML and MDS

Precision genomic profiling assay designed for myeloid malignancies (AML and MDS).

Focused on comprehensive analysis of myeloid disease-associated genomic alterations.

Uses blood or bone marrow samples with a capacity of ~20 samples per Ion 540™ Chip.

Book Test

Targeted Cancer Panels

NGS-based focused oncology and hereditary panels

PAN CANCER PANEL: 86 genes, 190 MSI targets, broad cancer profiling (1321 regions).

HOT SPOT PANEL: 86 cancer genes covering 1324 hotspot regions.

HEREDITARY ONCOLOGY PANEL: 47 genes for breast, ovarian & colorectal cancer (incl. BRCA1/2).

LUNG CANCER FUSION PANEL: Detects 17 fusion genes + 4 control genes for lung cancer.

Book Test

Liquid Biopsy | cfDNA Assay

Minimally invasive pancancer genomic insights from cell-free DNA

Blood or fluid-based test (ctDNA from blood, CSF, urine) avoiding surgical biopsy.

Detects SNVs, InDels, CNVs, and gene fusions across multiple cancer types.

Supports pan-cancer, lung, and breast cancer insights for early detection, MRD, recurrence, and treatment response.

Rapid NGS workflow with results in ~1 week using automated sequencing and analysis.

Book Test

Our Expertise

Nucleome specializes in advanced oncology genomics through high-throughput sequencing, multi-dimensional molecular profiling, and computational biology.

Technology Ecosystem

PacBio, Oxford Nanopore, Illumina NGS; Ion S5 and Axiom & GeneTitan microarrays.

Multi-Modal Profiling

SNVs, InDels, CNVs, fusions, MSI, TMB, LOH from tissue and liquid biopsy (cfDNA).

Bioinformatics & Clinical Interpretation

End-to-end NGS analytics with COSMIC, ClinVar, OncoKB annotation and AI-assisted reporting.

Epigenomics

DNA methylation profiling (EPIC array) and targeted methylome analysis (Twist panel).

Principal Scientist, Translational Biology Automotive industry Principal Scientist, Translational Biology Power engineering Principal Scientist, Translational Biology Mechanical engineering Principal Scientist, Translational Biology Biological engineering

Clinical solutions

Lorem ipsum dolor sit amet, detracto efficiantur per in, id decore ponderum legendos sed. Eu qui porro voluptua instructior, labor oporteat partiendo eu duo. Ignota impedit officiis et duo. Ex mei mundi eleifend, nisl justo intelleg quodsi. Est mucius audiam an. Ad sed erat pertinax vituperatoribus. Te vim quo postea possit reprimique, has ex fierent abhorreant scripserit purto euripidis tempor quodsi lorem.

Chemistry testing

Electrical signals

Biological evaluation

Toxicological assessment